<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Genistein</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01645</strong>&#160; (EXPT01582)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>investigational</td></tr><tr><th>Description</th><td><p>An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (<span class="caps">DNA</span> topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.</p>
<p>Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in <i>Felmingia vestita</i>, which is a plant traditionally used against worms. It has also been demonstrated to be effective against intestinal parasites such as the common liver fluke, pork trematode and poultry cestode. [Wikipedia]</p>
<p>Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women. <sup class="footnote" id="fnr1"><a href="#fn1">1</a></sup></p>
<p>Genistein can be found in food sources such as tofu, fava beans, soybeans, kudzu, and lupin. It is also present in certain cell cultures and medicinal plants. [Wikipedia]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01645/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01645/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01645.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01645.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01645.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01645.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01645.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01645">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>4',5, 7-Trihydroxyisoflavone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>5,7,4'-Trihydroxyisoflavone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Genisteol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Genisterin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Prunetol</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Sophoricol</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/protein-kinase-inhibitors">Protein Kinase Inhibitors</a></li>
<li><a href="/mesh/anticarcinogenic-agents">Anticarcinogenic Agents</a></li>
<li><a href="/mesh/phytoestrogens">Phytoestrogens</a></li></ul></td></tr><tr><th>CAS number</th><td>446-72-0</td></tr><tr><th>Weight</th><td>Average: 270.2369<br>Monoisotopic: 270.05282343</td></tr><tr><th>Chemical Formula</th><td>C<sub>15</sub>H<sub>10</sub>O<sub>5</sub></td></tr><tr><th>InChI Key</th><td>TZBJGXHYKVUXJN-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one</div></td></tr><tr><th>SMILES</th><td><div class="wrap">OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Isoflavonoids</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Isoflavonoids</td></tr><tr><th>Alternative parents</th><td>Stilbenes; Chromones; Phenols and Derivatives; Pyranones and Derivatives; Polyols; Enols; Polyamines</td></tr><tr><th>Substituents</th><td>stilbene; chromone; benzopyran; pyranone; phenol derivative; pyran; benzene; polyol; enol; polyamine</td></tr><tr><th>Classification description</th><td>This compound belongs to the isoflavonoids. These are natural products derived from 3-phenylchromen-4-one.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Currently Genistein is being studied in clinical trials as a treatment for prostate cancer.  </td></tr><tr><th>Pharmacodynamics</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mechanism of action</th><td>Genistein may inhibit cancer cell growth by blocking enzymes required for cell growth. 

Genistein may decrease cardiovascular risk in postmenopausal women by interacting with the nuclear estrogen receptors to alter the transcription of cell specific genes. In randomized clinical trials, genistein was seen to increase the ratio of nitric oxide to endothelin and improved flow-mediated endothelium dependent vasodilation in healthy postmenopausal women. [1] In addition, genistein may have beneficial effects on glucose metabolism by inhibiting islet tyrosine kinase activity as well as insulin release dependent on glucose and sulfonylurea. [1] </td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Genistein</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002433" target="_blank">Cytochrome P450 1A2</a></li></ul></td><td><a href="/metabolites/DBMET00251">3'-hydroxygenistein</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/252">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li>
<li>Helminthic Microorganisms</li>
<li>Parasitic nematodes and other roundworms</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9877</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.6785</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.7002</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9288</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7828</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9075</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7672</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9105</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.6821</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.9254</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8949</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9232</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.8881</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Inhibitor</td>
        <td>0.796</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.8009</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9638
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9276
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.8572
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          3.2988 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9569
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8917
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/1936">1H NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6381">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6382">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6383">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6384">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6385">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6386">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6387">MS/MS Spectrum LC-APPI-QQ (API2000) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6388">MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies	) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6389">MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 5</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6390">MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6391">MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6392">MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6393">MS/MS Spectrum LC-ESI-ITTOF (LCMS-IT-TOF) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/6394">MS/MS Spectrum LC-ESI-ITTOF (LCMS-IT-TOF) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/1871">[1H,13C] 2D NMR Spectrum</a></li></ul></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>